Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2019-02-21 | 2020-07-31 | 76489 |
| CLARUS | 40MG | CAPSULE | Resolved | 2019-03-05 | 2019-05-08 | 77763 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-04-03 | 2019-05-08 | 80416 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-07-09 | 2019-07-17 | 88979 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-07-23 | 2019-10-02 | 89821 |
| MYLAN-ATAZANAVIR | 150MG | CAPSULE | Resolved | 2019-10-15 | 2020-07-31 | 96531 |
| MYLAN-ATAZANAVIR | 300MG | CAPSULE | Resolved | 2019-10-15 | 2020-06-26 | 96534 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-10-29 | 2020-03-18 | 97440 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2019-12-11 | 2020-06-03 | 100921 |
| CLARUS | 40MG | CAPSULE | Avoided shortage | 2020-01-24 | 2020-01-28 | 104181 |
| CLARUS | 40MG | CAPSULE | Resolved | 2020-03-18 | 2020-04-08 | 108871 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2020-07-08 | 2020-10-14 | 119721 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2020-10-14 | 2020-10-20 | 126325 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-04-13 | 2021-06-24 | 137415 |
| CLARUS | 40MG | CAPSULE | Avoided shortage | 2021-06-30 | 2021-10-13 | 141672 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-06-30 | 2021-12-21 | 141675 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| MYLAN-ATAZANAVIR | 150MG | CAPSULE | Actual shortage | 2022-05-31 | 2022-05-31 | 161590 |
| MYLAN-ATAZANAVIR | 200MG | CAPSULE | Actual shortage | 2022-05-31 | 2022-05-31 | 161593 |
| MYLAN-ATAZANAVIR | 300MG | CAPSULE | Actual shortage | 2022-05-31 | 2022-05-31 | 161596 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |